Skip to main content

Volume 15 - Issue 10 - October 2007

09/04/2008
 At the risk of stating the obvious, a thriving and successful clinical-cosmetic practice requires satisfied and “happy” patients. In contrast, unsuccessful “struggling” practices often have dissatisfied and “unhappy” patients who will...
 At the risk of stating the obvious, a thriving and successful clinical-cosmetic practice requires satisfied and “happy” patients. In contrast, unsuccessful “struggling” practices often have dissatisfied and “unhappy” patients who will...
 At the risk of stating the...
09/04/2008
The Dermatologist
09/04/2008
  Some bleeding is an inevitable event following procedures with dermal filling agents or botulinum toxin type A. Yet, there are things you can do before and after procedures to reduce the amount of bruising patients experience. In...
  Some bleeding is an inevitable event following procedures with dermal filling agents or botulinum toxin type A. Yet, there are things you can do before and after procedures to reduce the amount of bruising patients experience. In...
  Some bleeding is an...
09/04/2008
The Dermatologist
09/04/2008
A zinc complex was recently developed to help restore functional elastin in photodamaged and aging skin. Until this discovery, there was no method to regenerate damaged elastin and restore resiliency to photoaged skin. Studies in the murine...
A zinc complex was recently developed to help restore functional elastin in photodamaged and aging skin. Until this discovery, there was no method to regenerate damaged elastin and restore resiliency to photoaged skin. Studies in the murine...
A zinc complex was recently...
09/04/2008
The Dermatologist
09/04/2008
FDA APPROVALS & NEWSFDA Approves Atralin (Tretinoin) Gel 0.05% for AcneThe U.S. Food and Drug Administration (FDA) has approved Coria Laboratories’ Atralin (tretinoin) Gel 0.05%, for topical treatment of acne vulgaris.Formulated in a...
FDA APPROVALS & NEWSFDA Approves Atralin (Tretinoin) Gel 0.05% for AcneThe U.S. Food and Drug Administration (FDA) has approved Coria Laboratories’ Atralin (tretinoin) Gel 0.05%, for topical treatment of acne vulgaris.Formulated in a...
FDA APPROVALS & NEWSFDA...
09/04/2008
The Dermatologist
09/04/2008
  To achieve the best outcomes, with minimal adverse effects, with poly-L-lactic acid (Sculptra), we offer our best practices, including patient selection, treatment planning, and avoiding adverse events, as well as our recommended...
  To achieve the best outcomes, with minimal adverse effects, with poly-L-lactic acid (Sculptra), we offer our best practices, including patient selection, treatment planning, and avoiding adverse events, as well as our recommended...
  To achieve the best...
09/04/2008
The Dermatologist

Column

Chief Medical Editor Message
09/04/2008
  I met with a group of pharmacy benefit managers to educate them about psoriasis treatment. They are in a great position to help us make sure patients get the care they need. They are also in a great position to really screw things...
  I met with a group of pharmacy benefit managers to educate them about psoriasis treatment. They are in a great position to help us make sure patients get the care they need. They are also in a great position to really screw things...
  I met with a group of...
09/04/2008
The Dermatologist